Institutional investors purchased a net $663.8 thousand shares of INSM during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 75.07% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
C WORLDWIDE ASSET MANAGEMENT FON... Bought 234.4 Thousand shares of Insmed Inc
CANDRIAM BELGIUM SA Bought 75.0 Thousand shares of Insmed Inc
STATE STREET GLOBAL ADVISORS LTD... Sold 3.6 Thousand shares of Insmed Inc